Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01052090
What this trial is testing

Safety and Efficacy Study in Hepatitis C Patients With PHN121

Who this might be right for
Hepatitis C Virus Infection
PhytoHealth Corporation 12
Large-scale testing (Phase 3)Study completedNCT02114151
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 103
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Early research (Phase 1)Study completedNCT01250366
What this trial is testing

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Who this might be right for
HCV (Genotype 1)
Bristol-Myers Squibb 70
Testing effectiveness (Phase 2)Study completedNCT01858766
What this trial is testing

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 379
Not applicableStudy completedNCT00863109
What this trial is testing

Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)

Who this might be right for
Hepatitis C, ChronicGenotype 1HCV-1
Merck Sharp & Dohme LLC 133
Large-scale testing (Phase 3)Study completedNCT01896193
What this trial is testing

Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 127
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Post-approval studies (Phase 4)Study completedNCT02761629
What this trial is testing

Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 180
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Early research (Phase 1)Study completedNCT00850044
What this trial is testing

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

Who this might be right for
HCV Infection
AbbVie 87
Not applicableStudy completedNCT01514890
What this trial is testing

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 675
Testing effectiveness (Phase 2)Study completedNCT01371604
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Study completedNCT02125500
What this trial is testing

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

Who this might be right for
Viral Hepatitis CHIV
ANRS, Emerging Infectious Diseases 68
Testing effectiveness (Phase 2)Ended earlyNCT01080222
What this trial is testing

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
Vertex Pharmaceuticals Incorporated 152
Testing effectiveness (Phase 2)Study completedNCT00735969
What this trial is testing

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 21
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Large-scale testing (Phase 3)Study completedNCT03833362
What this trial is testing

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Who this might be right for
Hepatitis C
R-Pharm 420
Large-scale testing (Phase 3)Study completedNCT01241760
What this trial is testing

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Genotype 1 Chronic Hepatitis CTreatment Naive
Janssen Infectious Diseases BVBA 744
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation